ライフサイエンスコーパス: antigen-presenting cell

1 r (TCR) for peptide-loaded MHCs (pMHC) on an antigen-presenting cell.

2 curs at the junction between a T cell and an antigen-presenting cell.

3 nflammatory cytokines and act as more potent antigen presenting cells.

4 g epitopes and block endocytosis of fVIII by antigen presenting cells.

5 apabilities in enhancing antigen delivery to antigen presenting cells.

6 ne response through TLR7 and TLR8 in various antigen presenting cells.

7 ent on the plasma membrane of thymocytes and antigen presenting cells.

8 plex class I (p-MHC I) proteins displayed by antigen-presenting cells.

9 toid dendritic cells (pDCs) are professional antigen-presenting cells.

10 selectively by CD8alpha(+) DCs but not other antigen-presenting cells.

11 rlay an arrangement of B cells, T cells, and antigen-presenting cells.

12 nd blocks IgE binding to CD23 on B cells and antigen-presenting cells.

13 in despite the absence of professional donor antigen-presenting cells.

14 ion of an immune synapse between T cells and antigen-presenting cells.

15 les across the mucosal barrier to underlying antigen-presenting cells.

16 SCIMP expression is restricted to antigen-presenting cells.

17 d CD8(+) T cell activation when expressed on antigen-presenting cells.

18 ted organs, cytokines, regulatory cells, and antigen-presenting cells.

19 ge of lacking passenger leukocytes including antigen-presenting cells.

20 ilitated allergen presentation to T cells by antigen-presenting cells.

21 ligently assess the ability of MCs to act as antigen-presenting cells.

22 mal stimulus and complete arrest on the best antigen-presenting cells.

23 en developing or mature lymphocytes and self-antigen-presenting cells.

24 increased ICOSL expression on GC B cells and antigen-presenting cells.

25 ndent activation, primarily by non-classical antigen-presenting cells.

26 ses through interactions between T cells and antigen-presenting cells.

27 with CD73 expressed by responder T cells and antigen-presenting cells.

28 engagement of Fcgamma receptors expressed on antigen-presenting cells.

29 antigens presented by MHC-family proteins on antigen-presenting cells.

30 L-15 plus 4-1BBL(+)IL-15Ralpha(+) artificial antigen-presenting cells.

31 script and decreased expression of HLA-DR on antigen-presenting cells.

32 RP150; and increased exosomal stimulation of antigen-presenting cells.

33 zation to foods can be mediated by cutaneous antigen-presenting cells.

34 used by interactions between CD4 T cells and antigen-presenting cells.

35 te to the inflammatory environment or act as antigen-presenting cells.

36 omplex molecules expressed on the surface of antigen-presenting cells.

37 surveillance, T cells survey the surface of antigen-presenting cells.

38 sues and are related to adult populations of antigen-presenting cells.

39 of dendritic cells to fulfill their role as antigen-presenting cells.

40 istocompatibility complex (MHC) molecules on antigen-presenting cells.

41 Cs in comparison with functionally competent antigen-presenting cells.

42 o changes in protein expression within these antigen-presenting cells.

43 histocompatibility complex II expression by antigen-presenting cells.

44 to represent the surface of HIV Env-bearing antigen-presenting cells.

45 ajor histocompatibility complex molecules on antigen-presenting cells.

46 The SB system combined with artificial antigen-presenting cells (aAPC) can selectively propagat

47 Others have proposed that antigen-presenting cell activation could be paradoxicall

48 ptor alpha (IL-15Ralpha) are co-expressed on antigen-presenting cells, allowing transpresentation of

49 oprotein-specific CD4(+) T cells, but not on antigen-presenting cells, amplified T-cell effector func

50 ominant and subdominant epitopes by the same antigen-presenting cell and may be overcome by distribut

51 CD40 agonists bind the CD40 molecule on antigen-presenting cells and activate them to prime tumo

52 Nbeta cells displayed features of antigen-presenting cells and activated virus-specific CD

53 Innate antigen-presenting cells and adaptive immune T cells hav

54 e a heterogeneous population of professional antigen-presenting cells and are key cells of the immune

55 philins mediate complex interactions between antigen-presenting cells and conventional alphabeta T ce

56 requires highly specific cooperation between antigen-presenting cells and distinct antigen-specific r

57 s, which in turn suppress autoantigen-loaded antigen-presenting cells and drive the differentiation o

58 ntigen-mediated interactions between mammary antigen-presenting cells and interferon-gamma (IFNgamma)

59 gastrointestinal lipids, and trafficking of antigen-presenting cells and lymphocytes to lymphoid org

60 However, many phagocytic cells also act as antigen-presenting cells and must balance degradation an

61 ested on a mixed lymphocyte reaction between antigen-presenting cells and recipient T cells.

62 madeltaT cells induced production of IL-6 by antigen-presenting cells and suppressed expression of in

63 Antigen-presenting cells and T cells are populations cus

64 the immune synapse at the interface between antigen-presenting cells and T cells assembles and organ

65 mental Cell, Plaks et al. (2015) reveal that antigen-presenting cells and T cells have a key role in

66 munogenicity, exhibiting increased uptake by antigen-presenting cells and T-cell stimulation compared

67 high cell surface expression of CD1c on key antigen-presenting cells and the discovery of its mycoba

68 calized inflammation including activation of antigen-presenting cells and vaginal recruitment of HIV

69 ritic cells (moDCs) that represent classical antigen-presenting cells and we aimed at studying IgE-de

70 n to induce activation of endothelial cells, antigen-presenting cells, and platelets, resulting in a

71 can function as non-professional tolerogenic antigen-presenting cells, and sustain the blood-testis b

72 the level of initial viral infection in the antigen-presenting cells, and the level determines the d

73 mal cellular compartment of BMDCs, increases antigen presenting cell (APC) trafficking to draining ly

74 the center of the T cell interface with the antigen presenting cell (APC).

75 Antigen presenting cells (APC) are critical components o

76 from emphysematous lung and in CD11c(+) lung antigen presenting cells (APC) of mice exposed to smoke.

77 of Blood, Wikstrom and colleagues highlight antigen-presenting cell (APC) dysfunction as a potential

78 allergen uptake, dendritic cell maturation, antigen-presenting cell (APC) function in T-cell polariz

79 nd presented on MHC by the target cell or an antigen-presenting cell (APC) in the tumor stroma.

80 hip between FLG-null mutations and epidermal antigen-presenting cell (APC) maturation in subjects wit

81 coordinated interactions of T cells with two antigen-presenting cell (APC) populations, B cells and d

82 g nonobese diabetic (NOD) mice contained two antigen-presenting cell (APC) populations: a major macro

83 addition to antigen and to identify the lung antigen-presenting cell (APC) types that sustain the sel

84 eptor that mediates stable interactions with antigen-presenting cell (APC), as well as chemokine-medi

85 CD4(+) and CD8(+) T-cell proliferation in an antigen-presenting cell (APC)-dependent manner.

86 esponse to specific infections or neoplasms, antigen-presenting cells (APC) and effector T cells form

87 ulation depends on a population of CD301b(+) antigen-presenting cells (APC) in the lamina propria.

88 nuclear cells (PBMC) yet ignore professional antigen-presenting cells (APC) that could reveal otherwi

89 The interaction of antigen-presenting cells (APC) with sensitized helper T

90 tracellular mycobacteria and may also act as antigen-presenting cells (APC).

91 instead transfer their antigens to CD11c(+) antigen-presenting cells (APC).

92 activation of ISR was observed in intestinal antigen presenting cells (APCs) and epithelial cells dur

93 with prominent infiltration of the skin with antigen presenting cells (APCs) and T cells.

94 tigen uptake, processing and presentation by antigen presenting cells (APCs) are tightly coupled proc

95 al-antigen-peptidoglycan (NAP) conjugates to antigen presenting cells (APCs) in intestinal lymphoid p

96 l as tumor-specific peptide neoantigens into antigen presenting cells (APCs) in lymph nodes for cance

97 been examining antigen presentation and the antigen presenting cells (APCs) in the islets of Langerh

98 res antigens to be exposed on the surface of antigen presenting cells (APCs) via MHC class II (MHC-II

99 ked" on different cells (recipient and donor antigen presenting cells (APCs), respectively).

100 tation of HSP-chaperoned peptides by CD91(+) antigen presenting cells (APCs), T cells are primed with

101 can act by down-regulating CD80 and CD86 on antigen presenting cells (APCs), thereby altering the le

102 lets of Langerhans normally contain resident antigen presenting cells (APCs), which in normal conditi

103 patibility complex (pMHC), on the surface of antigen presenting cells (APCs).

104 o the endosomal compartments of professional antigen presenting cells (APCs).

105 related with reduced type I IFN signaling in antigen-presenting cells (APCs) and decreased priming of

106 n Vgamma9Vdelta2 T cells can act in vitro as antigen-presenting cells (APCs) and induce alphabeta T-c

107 t AC-NPs deliver tumour-specific proteins to antigen-presenting cells (APCs) and significantly improv

108 supporting a role for B cells functioning as antigen-presenting cells (APCs) and/or regulatory cells

109 lls is restricted at local tumor sites where antigen-presenting cells (APCs) are frequently dysfuncti

110 Antigen-presenting cells (APCs) are key players in the i

111 Although antigen-presenting cells (APCs) are required for antigen

112 A number of previous studies have identified antigen-presenting cells (APCs) as key targets of Ebola

113 ompatibility complex (MHC) class II-positive antigen-presenting cells (APCs) both prior to and after

114 e cargo packaging and subsequent delivery to antigen-presenting cells (APCs) capable of triggering an

115 y, lower levels of viral infectivity in B6.S antigen-presenting cells (APCs) correlated with the dise

116 explored whether modulation of intratumoral antigen-presenting cells (APCs) could increase responses

117 st enter the thymic medulla, where they scan antigen-presenting cells (APCs) displaying a diverse arr

118 ited characteristics of both neutrophils and antigen-presenting cells (APCs) in early-stage human lun

119 Dendritic cells (DCs) are the professional antigen-presenting cells (APCs) in the lung.

120 Professional antigen-presenting cells (APCs) in the skin include dend

121 esence of tumor infiltrating lymphocytes and antigen-presenting cells (APCs) in the tumor.

122 However, whether a particular subset of antigen-presenting cells (APCs) is required during dieta

123 ribution of CD1d molecules on the surface of antigen-presenting cells (APCs) modulates activation of

124 Antigen-presenting cells (APCs) occupy diverse anatomica

125 c cells (mDCs) of smokers with emphysema and antigen-presenting cells (APCs) of mice exposed to smoke

126 Antigen-presenting cells (APCs) play an important role i

127 We investigated which antigen-presenting cells (APCs) produce RA in the human

128 ic cells (mDCs) are known as the most potent antigen-presenting cells (APCs) since they are also able

129 es, and antigen presentation by a variety of antigen-presenting cells (APCs) subsets.

130 Our data suggest that antigen-presenting cells (APCs) that can provide both IL

131 y isolated human neutrophils can function as antigen-presenting cells (APCs) to memory CD4(+) T cells

132 fic cognate interactions between T cells and antigen-presenting cells (APCs) when interferon-gamma (I

133 OX40L was expressed by myeloid antigen-presenting cells (APCs), but not B cells, in blo

134 T lymphocytes, upon activation by antigen-presenting cells (APCs), can undergo asymmetric

135 c cells (DCs) are considered the most potent antigen-presenting cells (APCs), which directly prime or

136 al replication and a failure to mature local antigen-presenting cells (APCs).

137 liferation and converting them into CD11c(+) antigen-presenting cells (APCs).

138 lex class II and co-stimulatory molecules on antigen-presenting cells (APCs).

139 resolved, particularly in the context of CNS antigen-presenting cells (APCs).

140 interaction with innate immune cells such as antigen-presenting cells (APCs).

141 cell populations of the immune system called antigen-presenting cells (APCs).

142 I) molecules on the surfaces of professional antigen-presenting cells (APCs).

143 e peptides bound to MHC molecules (pMHCs) on antigen-presenting cells (APCs).

144 ry T (Treg) cells by multiple mechanisms via antigen-presenting cells (APCs).

145 ng vaccine delivery system (PMVDS) to target antigen-presenting-cells (APCs) such as dendritic cells.

146 On the basis that donor bone marrow-derived antigen-presenting cells are eliminated within days of t

147 hat isolevuglandin-modified self-proteins in antigen-presenting cells are immunogenic, promoting cyto

148 apsid-specific CD8(+) T cells, whereas other antigen-presenting cells are not involved.

149 n-dependent interactions between T cells and antigen-presenting cells are vital for proper T cell act

150 endritic cells (DCs), which are professional antigen-presenting cells, are required for naive T-cell

151 regions of the dermis and form clusters with antigen presenting cells around hair follicles.

152 ulate proinflammatory cytokine production by antigen-presenting cells because of their differential I

153 en, effector T cells arrested transiently on antigen-presenting cells, briefly producing cytokine and

154 ome controls interleukin-1beta maturation in antigen-presenting cells, but a direct role for NLRP3 in

155 Dendritic cells are the most efficient antigen-presenting cells, but surprisingly little attent

156 Toll-like receptor 2 (TLR2) and Dectin 1 on antigen-presenting cells by zymosan results in a regulat

157 age Toll-like receptors (TLR) on T cells and antigen-presenting cells can act as potent immune adjuva

158 Here we show that subsets of antigen-presenting cells can be identified in fetal tiss

159 d plasma levels of pentraxin-2 and activated antigen-presenting cells, CD4 and CD8 T cells, and Th17-

160 Dendritic cells (DCs) are major antigen-presenting cells, central inducers of adaptive i

161 Gradual loss of membrane-tethered VTCN1 from antigen-presenting cells combined with an increased rele

162 D) development by expressing HLA-DQ8trans on antigen-presenting cells compared with HLA-DQ2 or -DQ8 h

163 Dendritic cells (DCs) are professional antigen presenting cells conventionally thought to media

164 rferon transcriptional responses, or myeloid antigen-presenting cell costimulatory molecule upregulat

165 severely compromised in the muscle, because antigen-presenting cells could not be promptly recruited

166 tor CCR6, which is expressed by the critical antigen presenting cells, dendritic cells.

167 xists on the role of the most potent type of antigen-presenting cells, dendritic cells.

168 s: as intact antigen on the surface of donor antigen-presenting cells (direct) and as self-restricted

169 a-CD3, suggesting that forces are applied to antigen-presenting cells during activation.

170 r dependent on the EPO receptor and CD131 on antigen-presenting cells, EPO induced the secretion of a

171 Dendritic cells (DCs) are efficient antigen-presenting cells equipped with various cell surf

172 We found that B cells serve as potent antigen-presenting cells ex vivo and restimulate in vivo

173 newborn adaptive immune system, and neonatal antigen presenting cells exhibited a different CD300 rec

174 Antigen-presenting cells expressing different HLA molecu

175 SMX-NO-specific responses were detected with antigen-presenting cells expressing HLA-DQB1*05:01 (pati

176 Arachis hypogaea, Ara h 1 and 2, and used as antigen-presenting cells for autologous CD4(+) T cells (

177 microparticles (MPs) which passively target antigen-presenting cells for intracellular release.

178 s that DCs need to be viewed not only as key antigen-presenting cells for lymphocytes but also as bro

179 e essential for adhesion between T-cells and antigen-presenting cells, formation of the immunological

180 in combination with polarizing cytokines and antigen-presenting-cell free costimulation, is a flexibl

181 Pulsing of antigen-presenting cells from HLA-DRB1*11- and HLA-DRB1*

182 filarial infection, including suppression of antigen-presenting cell function and downmodulation of f

183 of the CD47-SIRPalpha axis may also promote antigen-presenting cell function and thereby stimulate a

184 In vitro, the combination suppressed DC antigen-presenting cell function to T helper cells and D

185 on DC chemotaxis, calcium mobilization, and antigen-presenting cell function were measured.

186 r cognate ligands are critical for enhancing antigen-presenting cell functions and influencing T cell

187 be the mechanical properties of the opposing antigen-presenting cell, giving rise to different signal

188 tion related to enhanced function of myeloid antigen-presenting cells have been reported.

189 sive carrier facilitated antigen delivery to antigen presenting cells in the draining lymph nodes.

190 to 300nm diameter, and induced maturation of antigen presenting cells in vitro.

191 dendritic cells (DCs), which are the primary antigen-presenting cells in allergic asthma.

192 ariety of human monocyte-derived tolerogenic antigen-presenting cells in current development as cell-

193 ent cytosolic delivery of tumour antigens to antigen-presenting cells in draining lymph nodes, leadin

194 rt the concept that eosinophils might act as antigen-presenting cells in patients with FA.

195 thma, we investigated the role of B cells as antigen-presenting cells in priming and maintenance of T

196 epidermal tumors by regulating the number of antigen-presenting cells in skin.

197 B cells are unique among class II-restricted antigen-presenting cells in that they have a clonally re

198 The reduced presence of antigen-presenting cells in the absence of MIF was assoc

199 e found that MIF both recruits and maintains antigen-presenting cells in the dermis/epidermis.

200 ma cells and that concomitant stimulation of antigen-presenting cells in the tumor microenvironment b

201 peptide conjugates were promptly taken up by antigen presenting cells, including dendritic cells and

202 unique transcriptional signature in CD11b(+) antigen-presenting cells inducing the recruitment and lo

203 gradient created from stromal, lymphoid, or antigen presenting cell interactions.

204 gate whether the number of CD23 molecules on antigen-presenting cells is associated with IgE levels a

205 ed adhesion between alloreactive T cells and antigen-presenting cells is essential for allorejection.

206 nstrate that FcgammaR expression by CD11c(+) antigen-presenting cells is required to generate anti-tu

207 requires the costimulatory molecule CD70 on antigen-presenting cells, is a cardinal feature of adapt

208 jor histocompatibility class II (pMHC II) on antigen-presenting cells, is so weak that it was previou

209 eceptor (TCR) with antigen on the surface of antigen-presenting cells leads to cell spreading and sig

210 Bidirectional tuning of T cells and antigen-presenting cells leads to the definition of home

211 ith autologous dendritic cells, professional antigen-presenting cells loaded with melanoma antigens g

212 ation of GI-resident CD4(+) T cells, loss of antigen-presenting cells, loss of innate lymphocytes, an

213 unbalanced Toll-like receptor expression on antigen-presenting cells may be the cause of the impaire

214 eads to TH2 sensitization and to study which antigen-presenting cells mediate this process.

215 agnetovaccination, MRI was used to visualize antigen-presenting cell-mediated antigen capture and sub

216 Finally, mechanical properties of adherent antigen-presenting cells modulate cytokine production by

217 d targets, differentiation and activation of antigen presenting cells, modulation of T-cell activatio

218 ance induction processes to be the subset of antigen presenting cells most efficiently activating dia

219 Intestinal antigen-presenting cells, namely macrophages and dendrit

220 g of antigen synthesized within the infected antigen-presenting cell, not by classical processing of

221 Monocyte-derived antigen-presenting cells of both short and long telomere

222 e vesicles that are secreted by the sentinel antigen-presenting cells of the immune system: DCs.

223 hagocytose particles and act as professional antigen-presenting cells (pAPC).

224 Intestinal professional antigen presenting cells (pAPCs) recognize and respond t

225 nd the peptide editor H2-DM, in professional antigen-presenting cells (pAPCs).

226 Dendritic cells (DCs) are the most efficient antigen-presenting cells, playing a key role in the adap

227 were cocultured with anti-CD3 and autologous antigen presenting cells plus interleukin (IL)-2 in pres

228 risk women was measured after coculture with antigen-presenting cells preincubated with recombinant E

229 ught to be orchestrated by T cells primed by antigen-presenting cell presenting alloantigens.

230 figuration on DCs, we showed that artificial antigen-presenting cells presenting IL-15:IL-15Ralpha in

231 -specific T cells must find small numbers of antigen-presenting cells, proliferate and differentiate

232 when cell-cell contacts, such as those with antigen-presenting cells, provided a niche.

233 nses were attributed to Btn2a2 deficiency in antigen-presenting cells rather than T cells or nonhemat

234 accination was ascribed to a large number of antigen-presenting cells resident in the skin and ready

235 ry B cells, functional T-cell responses, and antigen-presenting cell responses were assessed in perip

236 ced ability of mif(-/-) L. major to activate antigen-presenting cells, resulting in a 2-fold reductio

237 Infection of antigen-presenting cells results in SPI-2 T3SS-dependent

238 scriptional profiling suggested that genital antigen-presenting cells sense gram-negative bacterial p

239 tes that innate immune cytokines produced in antigen-presenting cells stimulating the T cell immune r

240 leads to increased innate immune responses, antigen-presenting cell stimulation, and priming of over

241 of alloantigen, its presentation by various antigen-presenting cells, subsequent recognition by dono

242 Our data suggest that specific antigen-presenting cell subsets and the inhibitory recep

243 Analysis of the antigen-presenting cell subsets in the lungs revealed th

244 We analyzed the variable responses of antigen-presenting cell subsets to drug.

245 riers transferring antigen to more efficient antigen-presenting cells such as DCs.

246 class II-restricted antigen presentation by antigen-presenting cells such as dendritic cells and B c

247 se-1-dependent IL-1beta and IL-18 release in antigen-presenting cells such as macrophages and dendrit

248 ties of CNTs may influence antigen uptake by antigen presenting cells, such as dendritic cells (DCs),

249 Tolar explore how the physical properties of antigen-presenting cell surfaces affect how B cells inte

250 allergen exposure and sensitization involves antigen-presenting cells, T and B lymphocytes and result

251 into the role of MHC class II in regulating antigen-presenting cell-T cell interactions critical to

252 adapted this approach to alpha-syn using the antigen-presenting cell-targeting glucan microparticle (

253 at a novel vaccination modality combining an antigen-presenting cell-targeting glucan particle (GP) v

254 on of natural killer cells, macrophages, and antigen presenting cells that control tumor growth at th

255 tigen presentation molecules and function as antigen presenting cells that induce CD4+Foxp3+ regulato

256 infection, dendritic cells (DC) mature into antigen-presenting cells that activate T cells, linking

257 ut affecting major functions of macrophages, antigen-presenting cells that are crucial for T cell act

258 DCs are potent antigen-presenting cells that can modulate antiviral imm

259 Islets of Langerhans contain antigen-presenting cells that capture the proteins and p

260 tive potential and have developed artificial antigen-presenting cells that generate CD62L-enriched NK

261 ional dendritic cells (cDC) are professional antigen-presenting cells that induce immune activation o

262 The two subsets of cDCs are specialized antigen-presenting cells that initiate T cell immunity a

263 red the composition and phenotype of splenic antigen-presenting cells that led to their enhanced capa

264 Dendritic cells (DC) are professional antigen-presenting cells that orchestrate immune respons

265 angerhans cells (LCs) are epidermis-resident antigen-presenting cells that share a common ontogeny wi

266 nfection prevents naive T-cell activation by antigen-presenting cells, the mechanism underlying such

267 tely, whereas some progeny are terminated in antigen-presenting cells, thereby stimulating immunity.

268 though we found no evidence that they act as antigen-presenting cells, these neutrophils expressed ma

269 fferentiation of specific T cell subsets and antigen-presenting cells, thought to be relevant in the

270 CD4(+) T-cells by acting as non-professional antigen presenting cells through the processing and pres

271 CD6 facilitates adhesion between T cells and antigen-presenting cells through its interaction with CD

272 A delivery vector for direct transfection of antigen presenting cells to improve cellular and humoral

273 e binding of peptide-loaded MHC (pMHC) on an antigen-presenting cell to the T cell receptor (TCR) on

274 and dendritic cells in lymph nodes serve as antigen-presenting cells to activate T cell responses ag

275 B cells served as antigen-presenting cells to CD4+ T cells.

276 immune response, facilitating trafficking of antigen-presenting cells to draining lymph nodes.

277 ical synapses formed between CD4 T cells and antigen-presenting cells to facilitate the targeting and

278 Using artificial antigen-presenting cells to highlight the effect of IL-1

279 ered T cells generate forceful contacts with antigen-presenting cells to improve access to antigen.

280 unological players from epithelial cells and antigen-presenting cells to innate lymphoid cells and re

281 Extrinsic STING signaling is also needed for antigen-presenting cells to stimulate antitumor T-cell i

282 After homing of these antigen-presenting cells to the draining lymph node (LN)

283 pacity of the fetal immune system, including antigen-presenting cells, to detect and respond to such

284 ability of GVHD, once initiated by recipient antigen-presenting cells, to generate a profound, locali

285 Anti-E-selectin reduced the number of mature antigen-presenting cells trafficking to lymphoid tissue

286 13-acetate/ionomycin and CMV-peptide-loaded antigen-presenting cells was intact in CMV-tetramer(+)CD

287 As lymphoma B cells can act as antigen-presenting cells, we hypothesized that TNFRSF14

288 Through in vitro assays using engineered antigen-presenting cells, we were able to stimulate peri

289 radation of Bet v 1, Api g 1, and Mal d 1 by antigen-presenting cells were compared by using flow cyt

290 Peptides presented uniformly by thymic antigen-presenting cells were tolerated by clonal deleti

291 cytes can function as non-professional lipid antigen presenting cells, which may present an important

292 O induced the secretion of active TGFbeta by antigen-presenting cells, which in turn converted naive

293 e virus primarily replicated in professional antigen-presenting cells, which may explain why this LAV

294 ific Tregs rely on expansion with allogeneic antigen-presenting cells, which requires access to donor

295 melanocortin 5 receptor (MC5r) expression on antigen presenting cells with adenosine 2 A receptor (A2

296 the health of cells, the immune system tasks antigen-presenting cells with gathering antigens from ot

297 chestration of antigen cross-presentation in antigen-presenting cells with innate stimulation.

298 chestration of antigen cross-presentation in antigen-presenting cells with innate stimulation.

299 The encounter of antigen-presenting cells with T lymphocytes in secondary

300 ulation of CD4(+) T cells by hemozoin-loaded antigen-presenting cells within lymphoid tissues.